NLS Collaboration

Nanoform Finland has granted AstraZeneca a global online STARMAP license. STARMAP is a digital AI version of the CESS technology that enables in-silico experiments to determine which molecules should be nanoformed. The license will enable AstraZeneca to screen molecules from drug discovery through to lifecycle management, describes Nanoform in a press release. Access to compound […]

The two collaborators have announced the launch of Biotech Heights, a new research hub that will explore food and materials production using bioprocessing to create useful products from living cells or cell components. “Lund University’s research mission in this area revolves around the exploration and advancement of scalable biotechnology, which we see as a transformative […]

The Novo Nordisk Foundation (NNF) has awarded eleven new grants through its Research Infrastructure Programme. Scientific progress relies heavily on access to high-quality research infrastructure. The NNF is therefore awarding the new grants for the establishment of world-class research infrastructure supporting innovative research at Danish research institutions. The grants will fund both advanced equipment and […]

Novo Nordisk and Valo Health have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation powered by artificial intelligence (AI). The collaboration will leverage the capabilities of Valo’s Opal Computational Platform including access to real-world patient data, AI-enabled small molecule discovery and Biowire […]

Karolinska University Hospital’s director Björn Zoëga and Karolinska Institute’s rector Annika Östman Wernerson have signed an agreement to establish a new joint center for advanced cell, gene and tissue therapies. The new center, which has operations both in Huddinge/Flemingsberg and in Solna, will be named Karolinska ATMP-centrum. ATMP stands for Advanced Therapy Medicinal Products. “Already […]

Evaxion Biotech has initiated a novel pipeline program, EVX-B3, an AI-designed vaccine candidate against an undisclosed bacterial pathogen. The new vaccine project will be a collaboration between Evaxion and an undisclosed leading pharmaceutical company, leveraging unique assets and know-how from both organizations, states the company A collaborative and co-funded effort To develop an effective vaccine, […]